TP53 and neoplasm: USP2, mainly USP2-1, participates in tumorigenesis in various cancers through the potentiation of the cell cycle, mitosis, lipogenesis, metastasis, EMT, and anti-oxidation, while inhibiting p53-mediated tumor death.